Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 13/20 | 0.60 |
| ▸ | JAK1 | P23458 | 6/20 | 0.60 |
| ▸ | JAK3 | P52333 | 8/20 | 0.59 |
| ▸ | PTK2 | Q05397 | 5/20 | 0.59 |
| ▸ | FYN | P06241 | 2/20 | 0.48 |
| ▸ | IKBKB | O14920 | 1/20 | 0.48 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | TYK2 | P29597 | 1/20 | 0.48 |
| ▸ | SYK | P43405 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.48 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3213852 | 0.90 | JAK2 (0.72) | JAK2JAK1JAK3PTK2IKBKB | |
| SCHEMBL7977614 | 0.86 | JAK1 (0.82) | JAK2JAK1JAK3PTK2FYN | |
| SCHEMBL7964535 | 0.85 | JAK2 (0.66) | JAK2JAK1JAK3PTK2TYK2 | |
| SCHEMBL2274423 | 0.85 | JAK2 (0.60) | JAK2JAK1JAK3PTK2IKBKB | |
| SCHEMBL13073248 | 0.83 | JAK2 (0.67) | JAK2JAK1JAK3PTK2IKBKB | |
| SCHEMBL7974148 | 0.83 | JAK2 (0.69) | JAK2JAK1JAK3PTK2IKBKB | |
| SCHEMBL3659300 | 0.82 | JAK2 (0.66) | JAK2JAK1JAK3PTK2IKBKB | |
| SCHEMBL7978007 | 0.82 | JAK2 (0.72) | JAK2JAK1JAK3PTK2IKBKB | |
| SCHEMBL7977475 | 0.82 | JAK2 (0.58) | JAK2JAK1JAK3PTK2IKBKB | |
| SCHEMBL3584357 | 0.81 | JAK2 (0.70) | JAK2JAK1JAK3PTK2IKBKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010010188-A1 | NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES. | GALAPAGOS NV (BE) | 2010-01-28 | — | — | WO | disclosed |